These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9723533)

  • 1. Immunogenic (MHC class II+) cells are able to induce unresponsiveness when delivered with anti-CD4 monoclonal antibody.
    Niimi M; Morris PJ; Wood KJ
    Transplant Proc; 1998 Aug; 30(5):2450. PubMed ID: 9723533
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells.
    Niimi M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Matsumoto K; Hamano K; Esato K; Hara M; Wood KJ
    Transplant Proc; 2000 Nov; 32(7):2035. PubMed ID: 11120054
    [No Abstract]   [Full Text] [Related]  

  • 3. The thymus is essential for the development of operational tolerance induced by donor-specific transfusion plus anti-CD4 monoclonal antibody.
    Niimi M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Matsumoto K; Hamano K; Esato K; Wood KJ
    Transplant Proc; 2000 Nov; 32(7):2067. PubMed ID: 11120069
    [No Abstract]   [Full Text] [Related]  

  • 4. Blockade of CD4 is more tolerogenic than blockade of Ag presentation via self MHC class II antigens.
    Chen ZK; Frick T
    Transplant Proc; 2000 Nov; 32(7):2000. PubMed ID: 11120038
    [No Abstract]   [Full Text] [Related]  

  • 5. Bidirectional blockade of CD4 and MHC class II molecules is an effective immunosuppressive treatment.
    Ito H; Hamano K; Shirasawa B; Tsuboi H; Esato K; Wood KJ
    Transplant Proc; 1997; 29(1-2):1288-9. PubMed ID: 9123310
    [No Abstract]   [Full Text] [Related]  

  • 6. Intrathymic inoculation of donor B cells induced indefinite prolongation of fully allogeneic cardiac grafts but not islet or skin grafts.
    Niimi M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Matsumoto K; Hamano K; Esato K; Wood KJ
    Transplant Proc; 2000 Nov; 32(7):2020. PubMed ID: 11120047
    [No Abstract]   [Full Text] [Related]  

  • 7. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
    Saitovitch D; Morris PJ; Wood KJ
    Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen.
    Motoyama K; Lehmann M; Flye MW
    Transplant Proc; 1999; 31(1-2):1237-8. PubMed ID: 10083552
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral administration of alloantigen plus nondepleting anti-CD4 monoclonal antibody induces indefinite prolongation of fully allogeneic cardiac allografts.
    Niimi M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Matsumoto K; Hamano K; Esato K; Hara M; Wood KJ
    Transplant Proc; 2000 Mar; 32(2):259. PubMed ID: 10715410
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness.
    Saitovitch D; Bushell AR; Morris PJ; Wood KJ
    Transplant Proc; 1995 Feb; 27(1):117-8. PubMed ID: 7878834
    [No Abstract]   [Full Text] [Related]  

  • 11. FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies.
    Moffatt SD; Metcalfe SM
    Transplant Proc; 1999 Nov; 31(7):2740. PubMed ID: 10578271
    [No Abstract]   [Full Text] [Related]  

  • 12. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-type single MHC locus products combined with anti-CD4 MAb can induce tolerance to cardiac allografts which is dependent on active suppression.
    Saitovitch D; Morris PJ; Wood KJ
    Transplant Proc; 1995 Feb; 27(1):119-20. PubMed ID: 7878844
    [No Abstract]   [Full Text] [Related]  

  • 14. Small, resting B cells induce prolonged survival of cardiac allografts mismatched for single minor, but not multiple minor, single major, or multiple major and minor histocompatibility antigens.
    Niimi M; Morris PJ; Wood KJ
    Transplant Proc; 1997; 29(1-2):1171. PubMed ID: 9123259
    [No Abstract]   [Full Text] [Related]  

  • 15. Mice treated with anti-CD4 monoclonal antibody accept fully allogeneic thyroid grafts but reject second-donor-type thyroid grafts in maintenance phase.
    Niimi M; Takashina M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Kameyama K; Matsumoto K; Hamano K; Esato K
    Transplant Proc; 2000 Nov; 32(7):2086. PubMed ID: 11120078
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy.
    Shizuru JA; Seydel KB; Flavin TF; Wu AP; Kong CC; Hoyt EG; Fujimoto N; Billingham ME; Starnes VA; Fathman CG
    Transplantation; 1990 Sep; 50(3):366-73. PubMed ID: 1976282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intrathymic tolerance on mouse heart and skin allograft acceptance.
    Tu Y; Arima T; Flye MW
    Transplant Proc; 1997; 29(1-2):1063-4. PubMed ID: 9123200
    [No Abstract]   [Full Text] [Related]  

  • 18. Human parathyroid grafts survived and functioned in mice treated with anti-CD4 monoclonal antibody.
    Niimi M; Takashina M; Shirasugi N; Hamano K; Esato K; Matsumoto K; Ikeda Y; Takami H; Kodaira S; Kameyama K
    Transplant Proc; 2000 Aug; 32(5):1040. PubMed ID: 10936342
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative efficacy of liposomal FK 506 with FK 506 (tacrolimus) with and without anti-CD4/CD8 monoclonal antibodies.
    Moffatt SD; McAlister V; Calne RY; Metcalfe SM
    Transplant Proc; 1999 Nov; 31(7):2754. PubMed ID: 10578277
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral administration of alloantigen induces indefinite prolongation of MHC mismatched cardiac allografts.
    Niimi M; Morris PJ; Wood KJ
    Transplant Proc; 1999; 31(1-2):892. PubMed ID: 10083392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.